HuagongsheHuagongshe Chemistry Print Report · For research reference only
Aluminium lithium hydride → 3-{4-[3-(1-Methyl-1H-benzoimidazol-2-yl)-phenyl]-piperazin-1-ylmethyl}-morpholine-4-carboxylic acid tert-butyl ester
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Aluminium lithium hydride | HCID 21226445 | — |
| Reactant | 3-{4-[3-(1-Methyl-1H-benzoimidazol-2-yl)-phenyl]-piperazine-1-carbonyl}-morpholine-4-carboxylic acid tert-butyl ester | HCID 68671119 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 3-{4-[3-(1-Methyl-1H-benzoimidazol-2-yl)-phenyl]-piperazin-1-ylmethyl}-morpholine-4-carboxylic acid tert-butyl ester | HCID 68670186 | 43.6% |
Reaction Steps
To a solution of 3-{4-[3-(1-methyl-1H-benzoimidazol-2-yl)-phenyl]-piperazine-1-carbonyl}-morpholine-4-carboxylic acid tert-butyl ester (0.21 g, 0.42 mmol) in dry THF (3 mL) at room temperature under a nitrogen atmosphere was added lithium aluminium hydride (LiAlH4) (0.05 g, 1.27 mmol). The reaction was heated at reflux for 2 h. The solution was then cooled to room temperature, quenched with 15% NaOH and then extracted with dichloromethane (3×10 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude was then purified by Preparative HPLC to obtain 0.09 g (43%) of the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08592463B2 |
| Source dataset | uspto-grants-2013_11 |
| ORD ID | ord-859e2c8882bd476188cbd34e3924e1a4 |
| Source note | uspto-grants-2013_11 |